Brenntag enters into distribution agreement with Insempra for Omega-7 biolipid

Brenntag is extending its own-brand portfolio with a biotech ingredient that reflects the future of sustainable beauty. CosVivet™ ActiLipid O7 is a biotech biolipid that unites active performance, multifunctionality and sustainability in one powerful ingredient while additionally delivering sensory experience. It is based on Insempra's Omega-7 biolipid, which is designed to meet demand for high-performance, sustainable beauty solutions.

Lipids are essential for skin barrier strength, hydration, and elasticity, and are key to skin health, moisture retention, and soothing. With its high omega-7 content and unique composition, CosVivet™ ActiLipid O7 is reported to support moisturization and help maintain smooth, supple-looking skin, making it particularly suitable for sensitive and delicate skin care applications. CosVivet™ ActiLipid O7 combines multifunctional performance with a defined sensory profile, contributing to a silky, lightweight, and non-greasy skin feel, effortless spreadability, and an elegant finish. It is fully oil-soluble, compatible with lipophilic raw materials, and offers formulation flexibility across a wide range of skin care concepts. Produced through an advanced fermentation process, CosVivet™ ActiLipid O7 carries a sustainability profile aligned with current formulation expectations, according to the supplier.

CosVivet™ ActiLipid O7 is a clear yellow liquid with minimal odor, high thermal stability, and minimal impact on odor and color in finished formulations. It is fully soluble in oils, compatible with liposoluble raw materials, and positions as an alternative to oils such as sea buckthorn and macadamia without their variability constraints. Produced through precision fermentation, it carries a sustainability profile aligned with current formulation expectations, according to Brenntag.

Michael Wilkop, Brenntag Specialties regional president Beauty & Care EMEA, states, “We are excited to embark on this new offer which underscores our commitment to helping our customers access cutting-edge sustainable ingredients that meet evolving consumer demands. Insempra's expertise in industrial biotechnology, combined with Brenntag's global distribution network, technical capabilities, and Innovation and Application Centers, creates a powerful platform for delivering sustainable beauty solutions. This is the first of several innovative products we plan to introduce together.”

Jens Klein, CEO and founder of Insempra, added, "This distribution agreement with Brenntag represents a pivotal moment for Insempra as we scale our biotechnology innovations to reach the global beauty industry. Brenntag's unparalleled market reach, deep technical expertise, and commitment to sustainability make them the ideal partner to bring our Omega-7 biolipid and future products to market. This is only the beginning - we are already developing additional breakthrough ingredients that will continue to transform the beauty and personal care industry."